Oxford Nanopore Technologies (LSE:ONT) Debt-to-Equity : 0.07 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Debt-to-Equity?

Oxford Nanopore Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £4.3 Mil. Oxford Nanopore Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £37.3 Mil. Oxford Nanopore Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was £643.9 Mil. Oxford Nanopore Technologies's debt to equity for the quarter that ended in Dec. 2023 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Oxford Nanopore Technologies's Debt-to-Equity or its related term are showing as below:

LSE:ONT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.07 Max: 0.17
Current: 0.07

During the past 6 years, the highest Debt-to-Equity Ratio of Oxford Nanopore Technologies was 0.17. The lowest was 0.04. And the median was 0.07.

LSE:ONT's Debt-to-Equity is ranked better than
66.76% of 1065 companies
in the Biotechnology industry
Industry Median: 0.14 vs LSE:ONT: 0.07

Oxford Nanopore Technologies Debt-to-Equity Historical Data

The historical data trend for Oxford Nanopore Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Debt-to-Equity Chart

Oxford Nanopore Technologies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.17

0.13

0.04

0.05

0.07

Oxford Nanopore Technologies Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial					0.04	0.03	0.05	0.05	0.07

Competitive Comparison of Oxford Nanopore Technologies's Debt-to-Equity

For the Biotechnology subindustry, Oxford Nanopore Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Nanopore Technologies's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Debt-to-Equity falls into.

Oxford Nanopore Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Oxford Nanopore Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.322	+	37.333)	/	643.851
	=	0.06

Oxford Nanopore Technologies's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.322	+	37.333)	/	643.851
	=	0.06

Oxford Nanopore Technologies (LSE:ONT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Oxford Nanopore Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Nanopore Technologies (LSE:ONT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (LSE:ONT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

ONTTF:USA ONTl:UK 4R0:Germany

Address

Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ

Website

https://www.nanoporetech.com

Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (LSE:ONT) Headlines

No Headlines